BBT Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BBT Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-200,000	Closed	-$8.52M	–	160
2015 Q3	$8.52M	Hold	200,000	–	–	0.79%	48
2015 Q2	$9.11M	Hold	200,000	–	–	0.83%	46
2015 Q1	$7.59M	Hold	200,000	–	–	0.77%	42
2014 Q4	$5.66M	Hold	200,000	–	–	0.47%	52
2014 Q3	$5.06M	Hold	200,000	–	–	0.28%	92
2014 Q2	$5.84M	Hold	200,000	–	–	0.36%	77
2014 Q1	$5.18M	Sell	200,000 -35,335	-15%	-$943K	0.23%	109
2013 Q4	$6.06M	Hold	235,335	–	–	0.28%	84
2013 Q3	$6.29M	Hold	235,335	–	–	0.32%	74
2013 Q2	$5.78M	Buy	+235,335	New	+$4.68M	0.31%	88

Other funds holding PTLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BBT Capital Management's PTLA Position: Q4 2015 in Review

BBT Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2015, closing a stake of 200,000 shares — an estimated $8.52M sold.

BBT Capital Management first reported a position in PTLA in Q2 2013 and held it in 10 quarters. The position peaked at $9.11M in Q2 2015. 190 funds tracked by Wall St. Rank hold PTLA as of Q4 2015.

BBT Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
BBT Capital Management sold 200,000 Portola Pharmaceuticals, Inc. shares in Q4 2015, an estimated $8.52M.
BBT Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
BBT Capital Management's Portola Pharmaceuticals, Inc. position peaked at $9.11M in Q2 2015.
190 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2015.

Based on BBT Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.